Cancer Therapy
Radiolanthanides show promise in targeted cancer immunotherapy
Published in Gene Therapy Weekly, May 6th, 2004
"149Pm, 166Ho, and 177Lu possess a range of half-lives and alpha-beta- energies for targeted radiotherapy of cancer," scientists in the United States explained.
"149Pm-. 166Ho-, and 177Lu-DOTA-biotin were pretargeted to LS174T colorectal tumors in nude mice with CC49 scFvSA antibody-streptavidin fusion protein," in a study conducted by M.R. Lewis and colleagues at the University of Missouri.
"Tumor uptakes of 149Pm (22.9% ID/g), 166Ho (30.2% ID/g),...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-05-06)
More Articles from Gene Therapy Weekly
- Bioengineering
Reengineered salivary glands act as bioreactors for systemic gene therapies - Cancer Therapy
Therapy combining cisplatin and overexpressed CAD promotes tumor destruction - Gene Therapy
HIV/gammaretrovirus-based STAR vector packaging system evaluated - Hematology
Antisense RNA molecules select for molecules linked to sickle cell disease - Neuroscience
Genetically modified olfactory ensheathing cells facilitate spinal cord repair - Vector Development
Folate receptor-targeted lipid vesicles ferry oligodeoxynucleotides to tumors - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
